PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $41,000 | -12.8% | 13,846 | -18.7% | 0.00% | 0.0% |
| Q4 2017 | $47,000 | -19.0% | 17,029 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $58,000 | +52.6% | 17,029 | +48.7% | 0.00% | +50.0% |
| Q3 2016 | $38,000 | -2.6% | 11,453 | -6.7% | 0.00% | 0.0% |
| Q2 2016 | $39,000 | -20.4% | 12,275 | -17.3% | 0.00% | 0.0% |
| Q1 2016 | $49,000 | -29.0% | 14,849 | -24.0% | 0.00% | -33.3% |
| Q4 2015 | $69,000 | – | 19,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |